125 related articles for article (PubMed ID: 8788438)
1. Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat.
Wadenberg ML; Ahlenius S
Eur J Pharmacol; 1995 Dec; 294(1):247-51. PubMed ID: 8788438
[TBL] [Abstract][Full Text] [Related]
2. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
3. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
Wadenberg ML
J Neural Transm Gen Sect; 1992; 89(1-2):49-59. PubMed ID: 1418867
[TBL] [Abstract][Full Text] [Related]
4. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
Salmi P; Karlsson T; Ahlenius S
Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
6. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP.
Ahlenius S; Larsson K
Psychopharmacology (Berl); 1998 Jun; 137(4):374-82. PubMed ID: 9676898
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
Anderson JJ; Kask AM; Chase TN
Eur J Pharmacol; 1996 Jan; 295(2-3):163-8. PubMed ID: 8720580
[TBL] [Abstract][Full Text] [Related]
10. The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties.
Prinssen EP; Kleven MS; Koek W
Eur J Pharmacol; 1998 Sep; 356(2-3):189-92. PubMed ID: 9774248
[TBL] [Abstract][Full Text] [Related]
11. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
Anderson JJ; Randall S; Chase TN
J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
[TBL] [Abstract][Full Text] [Related]
12. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
Ozer H; Ekinci AC; Starr MS
Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
[TBL] [Abstract][Full Text] [Related]
14. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
Parashos SA; Marin C; Chase TN
Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
Papa SM; Engber TM; Boldry RC; Chase TN
Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
[TBL] [Abstract][Full Text] [Related]
16. Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task.
Koskinen T; Sirviö J
Brain Res Bull; 2001 Jan; 54(1):65-75. PubMed ID: 11226715
[TBL] [Abstract][Full Text] [Related]
17. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
Ogren SO; Fuxe K
Neurosci Lett; 1988 Mar; 85(3):333-8. PubMed ID: 2966309
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
[TBL] [Abstract][Full Text] [Related]
19. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
Skarsfeldt T; Arnt J; Hyttel J
Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
Njung'e K; Handley SL
Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
